Dermatologic Disorders (Print Books are Bulk Sales Only)

Contemporary Diagnosis <br/>and Management in Dermatoprevention: <br/>Psoriasis and Its Comorbidities<sup>®</sup>
  • Code: DermPrev
  • Suggested Retail Price: $24.99
  • Availability: Print Bulk Orders

Contemporary Diagnosis
and Management in Dermatoprevention:
Psoriasis and Its Comorbidities®

Foreword by Steven R. Feldman, MD, PhD

Afterword by Nehal N. Mehta, MD, MSCE

Drs. Leon, Liao, and Koo have taken on the task of creating a much-needed handbook on the comorbidities of psoriasis, enumerating and categorizing them in a clinically oriented fashion and preparing dermatologists with the information they need to optimize the management of comorbidities in their psoriasis patients. The authors provide just enough background on each comorbidity to help clinicians recognize and screen for it, and, most importantly, they offer practical advice on how to manage these comorbidities.

John Y. M. Koo, MD, FAAD

John Y. M. Koo, MD, FAAD

Director, Psoriasis and Skin Treatment Center 
Professor and Vice Chairman
Department of Dermatology, 
University of California Medical Center, San Francisco

Argentina Leon, MD

Argentina Leon, MD

Clinical Psoriasis Research Fellow,
Department of Dermatology,
University of California, San Francisco;
Psoriasis and Skin Treatment Center,
Department of Dermatology,
University of California, San Francisco
Wilson J. Liao, MD

Wilson J. Liao, MD

Diplomate, American Board of Dermatology
Associate Professor, Department of Dermatology,
University of California, San Francisco;
Director, Psoriasis and Skin Treatment Center,
Department of Dermatology,
University of California, San Francisco

Table of Contents

Foreword by Steven R. Feldman, MD, PhD
Part I. Introduction
Part II. Comorbidities in Psoriasis
           Chapter 1: Cardiovascular Disease
           Chapter 2: Metabolic Syndrome, Diabetes,
                           Hypertension, and Dyslipidemia
           Chapter 3: Obesity
           Chapter 4: Depression
           Chapter 5: Psoriatic Arthritis
           Chapter 6: Malignancy
           Chapter 7: Other Comorbidities
Part III. Questions and Answers
Part IV. Future Directions
Part V. Conclusion
Part VI. Afterword by Nehal N. Mehta, MD, MSCE
Part VII. Appendices
Part VIII. Index